Moderna MRNA Net product sales — Total Revenue

Other product segments

Similar metrics at other companies

CRMDProduct sales, net — Total Revenue

$121.92M+212%

TVTXTotal net product sales — Total Revenue

$124.49M+64.1%

PTH

PTHSNet product revenues — Total Revenue

$10.67M—

MRAMProduct sales — Total Revenue

$15.31M+38.1%

NVAXProduct sales — Total Revenue

$18.85M+75.8%

TDCProduct Sales — Total Revenue

$371M+3.9%

FAQ

What is Moderna's net product sales — total revenue?

Moderna (MRNA) reported net product sales — total revenue of $352M in Q1 2026.

How has Moderna's net product sales — total revenue changed year-over-year?

Moderna's net product sales — total revenue increased by 309.3% year-over-year, from $86M to $352M.

What is the long-term trend for Moderna's net product sales — total revenue?

Over 4 years (2021 to 2025), Moderna's net product sales — total revenue has grown at a -43.4% compound annual growth rate (CAGR), from $17.68B to $1.82B.

What does net product sales — total revenue mean?

This represents the total net revenue recognized from the sale of commercial products within a specific business segment after accounting for all variable considerations. It reflects the actual economic value realized by the company from its product portfolio, excluding adjustments for returns, rebates, and discounts.